Characterization of differences in immune responses during bolus and continuous infusion endotoxin challenges using mathematical modeling

TL;DR

This study uses mathematical modeling to compare immune responses to endotoxin administered as a bolus versus continuous infusion, revealing distinct cytokine dynamics and underlying mechanisms.

Contribution

It introduces a mathematical model analyzing cytokine responses, identifying key parameter differences between bolus and continuous endotoxin administration.

Findings

Bolus injection causes higher IL-8 peaks.

Continuous infusion results in higher IL-10 peaks.

Continuous infusion prolongs inflammation with recurrent peaks.

Abstract

Endotoxin administration is commonly used to study the inflammatory response, and though traditionally given as a bolus injection, it can be administered as a continuous infusion over multiple hours. Several studies hypothesize that the latter better represents the prolonged and pronounced inflammation observed in conditions like sepsis. Yet, very few experimental studies have administered endotoxin using both strategies, leaving significant gaps in determining the underlying mechanisms responsible for their differing immune responses. We use mathematical modeling to analyze cytokine data from two studies administering a 2 ng/kg dose of endotoxin, one as a bolus and the other as a continuous infusion over four hours. Using our model, we simulate the dynamics of mean and subject-specific cytokine responses as well as the response to long-term endotoxin administration. Cytokine measurements reveal that the bolus injection leads to significantly higher peaks for IL-8, while IL-10 reaches significantly higher peaks during continuous administration. Moreover, the peak timing of all measured cytokines occurs later in the continuous infusion. We identify three model parameters that significantly differ between the two administration methods. Monocyte activation of IL-10 is greater during the continuous infusion, while recovery rates of IL-8 is faster for the bolus injection. This suggests that a continuous infusion elicits a stronger, longer-lasting systemic reaction through increased stimulation of monocyte anti-inflammatory mediator production and decreased recovery of pro-inflammatory catalysts. Furthermore, our continuous infusion model exhibits prolonged inflammation with recurrent peaks resolving within two days during long-term (20-32 hours) endotoxin administration.